Correlation
The correlation between EBS and NVDA is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
EBS vs. NVDA
Compare and contrast key facts about Emergent BioSolutions Inc. (EBS) and NVIDIA Corporation (NVDA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: EBS or NVDA.
Performance
EBS vs. NVDA - Performance Comparison
Loading data...
Key characteristics
EBS:
0.20
NVDA:
0.38
EBS:
1.34
NVDA:
0.84
EBS:
1.18
NVDA:
1.11
EBS:
0.35
NVDA:
0.51
EBS:
0.77
NVDA:
1.24
EBS:
43.83%
NVDA:
15.09%
EBS:
123.15%
NVDA:
58.96%
EBS:
-98.89%
NVDA:
-89.73%
EBS:
-95.32%
NVDA:
-9.56%
Fundamentals
EBS:
$350.63M
NVDA:
$3.39T
EBS:
-$2.52
NVDA:
$3.01
EBS:
1.55
NVDA:
1.64
EBS:
0.36
NVDA:
22.86
EBS:
0.63
NVDA:
39.31
EBS:
$960.00M
NVDA:
$148.52B
EBS:
$303.40M
NVDA:
$104.12B
EBS:
$106.30M
NVDA:
$90.97B
Returns By Period
In the year-to-date period, EBS achieves a -33.89% return, which is significantly lower than NVDA's 0.63% return. Over the past 10 years, EBS has underperformed NVDA with an annualized return of -13.82%, while NVDA has yielded a comparatively higher 74.01% annualized return.
EBS
-33.89%
28.46%
-37.55%
10.88%
-42.34%
-40.32%
-13.82%
NVDA
0.63%
21.07%
-2.24%
23.29%
93.53%
72.51%
74.01%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
EBS vs. NVDA — Risk-Adjusted Performance Rank
EBS
NVDA
EBS vs. NVDA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Emergent BioSolutions Inc. (EBS) and NVIDIA Corporation (NVDA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
EBS vs. NVDA - Dividend Comparison
EBS has not paid dividends to shareholders, while NVDA's dividend yield for the trailing twelve months is around 0.02%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EBS Emergent BioSolutions Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 5.65% | 0.00% | 0.00% |
NVDA NVIDIA Corporation | 0.02% | 0.02% | 0.03% | 0.11% | 0.05% | 0.12% | 0.27% | 0.46% | 0.29% | 0.45% | 1.20% | 1.70% |
Drawdowns
EBS vs. NVDA - Drawdown Comparison
The maximum EBS drawdown since its inception was -98.89%, which is greater than NVDA's maximum drawdown of -89.73%. Use the drawdown chart below to compare losses from any high point for EBS and NVDA.
Loading data...
Volatility
EBS vs. NVDA - Volatility Comparison
Emergent BioSolutions Inc. (EBS) has a higher volatility of 40.84% compared to NVIDIA Corporation (NVDA) at 10.81%. This indicates that EBS's price experiences larger fluctuations and is considered to be riskier than NVDA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
EBS vs. NVDA - Financials Comparison
This section allows you to compare key financial metrics between Emergent BioSolutions Inc. and NVIDIA Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
EBS vs. NVDA - Profitability Comparison
EBS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, Emergent BioSolutions Inc. reported a gross profit of 133.70M and revenue of 222.20M. Therefore, the gross margin over that period was 60.2%.
NVDA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported a gross profit of 26.67B and revenue of 44.06B. Therefore, the gross margin over that period was 60.5%.
EBS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, Emergent BioSolutions Inc. reported an operating income of 49.90M and revenue of 222.20M, resulting in an operating margin of 22.5%.
NVDA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported an operating income of 21.64B and revenue of 44.06B, resulting in an operating margin of 49.1%.
EBS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, Emergent BioSolutions Inc. reported a net income of 68.00M and revenue of 222.20M, resulting in a net margin of 30.6%.
NVDA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2025, NVIDIA Corporation reported a net income of 18.78B and revenue of 44.06B, resulting in a net margin of 42.6%.